Begg’s and Egger’s tests showed no publication bias between ESRα Pvull, ESRα Xbal, ESRβ Alul, and ESRβ Rsal polymorphisms and prostate cancer (Figure 4). This evidence concerns the gene ESR1 and prostate carcinoma.